{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:50:39Z","timestamp":1785239439973,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.vaccine.2022.09.018","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T04:08:18Z","timestamp":1663214898000},"page":"6107-6113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunogenicity and protective efficacy of a prototype pneumococcal bioconjugate vaccine"],"prefix":"10.1016","volume":"40","author":[{"given":"Javid","family":"Aceil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy V.","family":"Paschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory J.","family":"Knoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd S.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichollas E.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario F.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1902-7532","authenticated-orcid":false,"given":"Fikri Y.","family":"Avci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.09.018_b0005","unstructured":"WHO. World Health Organization (WHO) Pneumoniae Fact Sheet. World Health Organization Report 2019. <https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/pneumonia> [cited 2022 April 28]."},{"issue":"7","key":"10.1016\/j.vaccine.2022.09.018_b0010","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2022.09.018_b0015","unstructured":"CDC. Vaccines for Children (VFC) [cited 2022 February 22]. <https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/index.html>."},{"issue":"46","key":"10.1016\/j.vaccine.2022.09.018_b0020","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1016\/j.vaccine.2009.06.013","article-title":"Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges","volume":"27","author":"Frasch","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.018_b0025","doi-asserted-by":"crossref","unstructured":"Avci F, et al. Glycoconjugates: what it would take to master these well-known yet little-understood immunogens for vaccine development. mSphere 2019; 4(5): e00520\u201319.","DOI":"10.1128\/mSphere.00520-19"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.018_b0030","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.018_b0035","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/21645515.2018.1564444","article-title":"Invasive pneumococcal disease in relation to vaccine type serotypes","volume":"15","author":"Wantuch","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.018_b0040","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1080\/21645515.2018.1470726","article-title":"Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them","volume":"14","author":"Wantuch","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.vaccine.2022.09.018_b0045","doi-asserted-by":"crossref","first-page":"e00316","DOI":"10.1128\/IAI.00316-18","article-title":"Enzymatic hydrolysis of pneumococcal capsular polysaccharide renders the bacterium vulnerable to host defense","volume":"86","author":"Middleton","year":"2018","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2022.09.018_b0050","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/nm.2535","article-title":"A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design","volume":"17","author":"Avci","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.018_b0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/mmi.12265","article-title":"Pour some sugar on it: the expanding world of bacterial protein O-linked glycosylation","volume":"89","author":"Iwashkiw","year":"2013","journal-title":"Mol Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2022.09.018_b0060","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1073\/pnas.0500044102","article-title":"Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli","volume":"102","author":"Feldman","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.vaccine.2022.09.018_b0065","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1128\/JB.01318-07","article-title":"Functional characterization of bacterial oligosaccharyltransferases involved in O-linked protein glycosylation","volume":"189","author":"Faridmoayer","year":"2007","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.018_b0070","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41467-019-08869-9","article-title":"A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host","volume":"10","author":"Harding","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.018_b0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"On the mechanisms of conjugate vaccines","volume":"116","author":"Rappuoli","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2022.09.018_b0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fmicb.2014.00381","article-title":"Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery","volume":"5","author":"Garcia-Quintanilla","year":"2014","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.018_b0085","doi-asserted-by":"crossref","first-page":"150243","DOI":"10.1098\/rsob.150243","article-title":"Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli","volume":"6","author":"Kay","year":"2016","journal-title":"Open Biol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.09.018_b0090","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1021\/acsinfecdis.1c00415","article-title":"Development and immunogenicity of a prototype multivalent group b streptococcus bioconjugate vaccine","volume":"7","author":"Duke","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.018_b0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1475-2859-9-61","article-title":"Production of glycoprotein vaccines in Escherichia coli","volume":"9","author":"Ihssen","year":"2010","journal-title":"Microb Cell Fact"},{"issue":"37","key":"10.1016\/j.vaccine.2022.09.018_b0100","doi-asserted-by":"crossref","first-page":"18655","DOI":"10.1073\/pnas.1907833116","article-title":"A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae","volume":"116","author":"Feldman","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.018_b0105","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/IAI.01579-06","article-title":"Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice","volume":"75","author":"Marks","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.09.018_b0110","article-title":"Opsonophagocytic killing assay to assess immunological responses against bacterial pathogens","volume":"146","author":"Paschall","year":"2019","journal-title":"J Vis Exp"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.018_b0115","first-page":"1192","article-title":"A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS","volume":"31","author":"Knoot","year":"2021","journal-title":"Glycobiology"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.018_b0120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal Capsules and Their Types: Past, Present, and Future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2022.09.018_b0125","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/IAI.66.5.2186-2192.1998","article-title":"Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy","volume":"66","author":"Wessels","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.018_b0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1086\/315285","article-title":"Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate","volume":"181","author":"Paoletti","year":"2000","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.018_b0135","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1128\/IAI.67.9.4935-4938.1999","article-title":"Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination","volume":"67","author":"Lottenbach","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.018_b0140","doi-asserted-by":"crossref","first-page":"101453","DOI":"10.1016\/j.jbc.2021.101453","article-title":"Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine design","volume":"298","author":"Duke","year":"2022","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.018_b0145","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/CVI.00402-10","article-title":"Impact of the conjugation method on the immunogenicity of streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines","volume":"18","author":"Poolman","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2022.09.018_b0150","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/CVI.00122-06","article-title":"Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity","volume":"13","author":"Michon","year":"2006","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:18:16Z","timestamp":1759403896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22011124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0264410X22011124"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and protective efficacy of a prototype pneumococcal bioconjugate vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}